BioSpace News Archive

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that it has completed the sale of select operating assets and intellectual property (IP), including the Vectra® test, from Myriad Genetics’ autoimmune business unit to Labcorp (NYSE: LH) for $150 million in cash.

Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical stage biotherapeutics company focused on the oral delivery of biologics, today reported financial results for the second quarter ended June 30, 2021 and provided a corporate update.

Benitec Biopharma, Inc. today announced that Jerel A. Banks , M.D., Ph.D., Executive Chairman and Chief Executive Officer will present at the H.C. Wainwright 23rd Annual Global Investment Conference.

Champions Oncology, Inc., leaders in transformative technology solutions utilized in drug discovery and development, announced its financial results for its first quarter of fiscal 2022, ended July 31, 2021.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will host a webcast on Wednesday, October 13, 2021 at 4:30 p.m. ET / 9:30 p.m. IST

Nyxoah today announced that Olivier Taelman, Chief Executive Officer, will participate at the Cantor 2021 Global Healthcare Conference on Tuesday, September 28, 2021, with a virtual presentation at 4:00 pm CET/10:00 am ET.

Inhibrx, Inc., a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates, announced that the Company will be presenting at the following upcoming virtual investor conference.

Incyte today announced that multiple abstracts highlighting data for ruxolitinib cream, an investigational topical JAK1/JAK2 inhibitor, in patients with vitiligo and atopic dermatitis (AD) will be presented at the upcoming European Academy of Dermatology and Venereology (EADV) 30th Anniversary Congress, held virtually from September 29-October 2, 2021.

Labcorp today announced that it has closed its acquisition of select operating assets and intellectual property (IP) from Myriad Genetics’ autoimmune business unit, including the Vectra ® rheumatoid arthritis (RA) assay.

Genocea Biosciences, Inc. today announced that Jennifer Herron, Senior Vice President & Chief Commercial Officer at ADC Therapeutics SA (“ADCT”), has joined its board of directors.